From GlobeNewswire: 2025-06-03 08:00:00

Solid Biosciences Inc. announced the grant of 34,550 restricted stock units to two new employees, vesting in four installments over four years. The grant was made under the 2024 Inducement Stock Incentive Plan as a hiring inducement. Solid Biosciences is a precision genetic medicine company focusing on rare neuromuscular and cardiac diseases, with a diverse pipeline of gene therapy candidates. The company aims to improve the lives of patients with rare diseases through innovative technologies. For more information, visit www.solidbio.com. Contact Nicole Anderson for Investor Relations and Glenn Silver for Media.



Read more at GlobeNewswire: Solid Biosciences Reports Inducement Grants Under Nasdaq